Search research articles
Contact Us
Filters
Showing results (131-140 of 161) with videos related to
Page
of 17
Sort By:
European Journal of Pharmacology
|
December 22, 2015
Evaluation of the role of N-methyl-D-aspartate (NMDA) receptors in insulin secreting beta-cells
Steven Patterson, Nigel Irwin, Hong Guo-Parke, et al.
Diabetologia
|
June 26, 2014
A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation
Aisling M Lynch, Nupur Pathak, Varun Pathak, et al.
Peptides
|
September 27, 2005
Effects on glucose homeostasis and insulin secretion of long term activation of the glucose-dependent insulinotropic polypeptide (GIP) receptor by N-AcGIP(LysPAL37) in normal mice
Nigel Irwin, Brian D Green, Victor A Gault, et al.
European Journal of Pharmacology
|
September 24, 2014
Comparison of stability, cellular, glucose-lowering and appetite supressing effects of oxyntomodulin analogues modified at the N-terminus
Aisling M Lynch, Nupur Pathak, Yasmin E Flatt, et al.
Peptides
|
November 19, 2019
Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic Glu<sup>CreERT2</sup>;ROSA26-eYFP mice
Dipak Sarnobat, R Charlotte Moffett, Victor A Gault, et al.
Peptides
|
June 17, 2026
P1642-1, a novel pancreatic polypeptide analogue, ameliorates cognitive impairment in 5×FAD mice and is associated with enhanced PINK1/Parkin-related mitophagy
Huan Zhang, Yinuo Wei, Enhua Liu, et al.
Plos One
|
April 1, 2016
Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin
Christine M Martin, Vadivel Parthsarathy, Annie Hasib, et al.
Molecular and Cellular Endocrinology
|
April 20, 2023
The glucagon receptor antagonist desHis<sup>1</sup>Pro<sup>4</sup>Glu<sup>9</sup>-glucagon(Lys<sup>12</sup>PAL) alters alpha-cell turnover and lineage in mice, but does not cause alpha-cell hyperplasia
Ryan Lafferty, Neil Tanday, Vaibhav Dubey, et al.
Biological Chemistry
|
January 31, 2007
Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes
Victor A Gault, Kerry Hunter, Nigel Irwin, et al.
Molecular Medicine Reports
|
March 12, 2015
Effects of glucose-dependent insulinotropic polypeptide receptor knockout and a high-fat diet on cognitive function and hippocampal gene expression in mice
Rachel Lennox, Rachael R Lennox, R Charlotte Moffett, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 161) with videos related to
Sort By:
Page
of 17
European Journal of Pharmacology
|
December 22, 2015
Evaluation of the role of N-methyl-D-aspartate (NMDA) receptors in insulin secreting beta-cells
Steven Patterson, Nigel Irwin, Hong Guo-Parke, et al.
Diabetologia
|
June 26, 2014
A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation
Aisling M Lynch, Nupur Pathak, Varun Pathak, et al.
Peptides
|
September 27, 2005
Effects on glucose homeostasis and insulin secretion of long term activation of the glucose-dependent insulinotropic polypeptide (GIP) receptor by N-AcGIP(LysPAL37) in normal mice
Nigel Irwin, Brian D Green, Victor A Gault, et al.
European Journal of Pharmacology
|
September 24, 2014
Comparison of stability, cellular, glucose-lowering and appetite supressing effects of oxyntomodulin analogues modified at the N-terminus
Aisling M Lynch, Nupur Pathak, Yasmin E Flatt, et al.
Peptides
|
November 19, 2019
Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic Glu<sup>CreERT2</sup>;ROSA26-eYFP mice
Dipak Sarnobat, R Charlotte Moffett, Victor A Gault, et al.
Peptides
|
June 17, 2026
P1642-1, a novel pancreatic polypeptide analogue, ameliorates cognitive impairment in 5×FAD mice and is associated with enhanced PINK1/Parkin-related mitophagy
Huan Zhang, Yinuo Wei, Enhua Liu, et al.
Plos One
|
April 1, 2016
Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin
Christine M Martin, Vadivel Parthsarathy, Annie Hasib, et al.
Molecular and Cellular Endocrinology
|
April 20, 2023
The glucagon receptor antagonist desHis<sup>1</sup>Pro<sup>4</sup>Glu<sup>9</sup>-glucagon(Lys<sup>12</sup>PAL) alters alpha-cell turnover and lineage in mice, but does not cause alpha-cell hyperplasia
Ryan Lafferty, Neil Tanday, Vaibhav Dubey, et al.
Biological Chemistry
|
January 31, 2007
Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes
Victor A Gault, Kerry Hunter, Nigel Irwin, et al.
Molecular Medicine Reports
|
March 12, 2015
Effects of glucose-dependent insulinotropic polypeptide receptor knockout and a high-fat diet on cognitive function and hippocampal gene expression in mice
Rachel Lennox, Rachael R Lennox, R Charlotte Moffett, et al.
Page
of 17